Respiratory virus detections in children presenting to an Australian paediatric referral hospital pre-COVID-19 pandemic, January 2014 to December 2019
- PMID: 39841690
- PMCID: PMC12140113
- DOI: 10.1371/journal.pone.0313504
Respiratory virus detections in children presenting to an Australian paediatric referral hospital pre-COVID-19 pandemic, January 2014 to December 2019
Abstract
Acute respiratory infections cause significant paediatric morbidity, but for pathogens other than influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, systematic monitoring is not commonly performed. This retrospective analysis of six years of routinely collected respiratory pathogen multiplex PCR testing at a major paediatric hospital in New South Wales Australia, describes the epidemiology, year-round seasonality, and co-detection patterns of 15 viral respiratory pathogens. 32,599 respiratory samples from children aged under 16 years were analysed. Most samples were associated with a hospital admission (24,149, 74.1%) and the median age of sampling was 16 months (IQR 5-53). Viruses were detected in 62.9% (20,510) of samples, with single virus detections occurring in 73.5% (15,082) of positive samples. In instances of single virus detection, rhinovirus was most frequent (5125, 40.6%), followed by RSV-B (1394, 9.2%) and RSV-A (1290, 8.6%). Moderate to strong seasonal strength was observed for most viruses with some notable exceptions. Rhinovirus and enterovirus were detected year-round and low seasonal strength was observed for adenovirus and bocavirus. Biennial seasonal patterns were observed for influenza B and parainfluenza virus 2. Co-detections occurred in 5,428 samples, predominantly with two (4284, 79.0%) or three viruses (904, 16.7%). The most common co-detections were rhinovirus-adenovirus (566, 10.4%), rhinovirus-enterovirus (357, 8.3%), and rhinovirus-RSV-B (337, 7.9%). Ongoing pan-pathogen surveillance, integrating both laboratory and clinical data, is necessary to assist in identification of key pathogens and combination of pathogens to support effective preventative public health strategies and reduce the burden of paediatric respiratory infections.
Copyright: © 2025 Burrell et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors declare no conflict of interest for this study publication.
Figures


Similar articles
-
Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023/2024 respiratory viral season.Microbiol Spectr. 2024 Oct 3;12(10):e0111624. doi: 10.1128/spectrum.01116-24. Epub 2024 Aug 20. Microbiol Spectr. 2024. PMID: 39162510 Free PMC article.
-
Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic.J Gen Virol. 2024 May;105(5). doi: 10.1099/jgv.0.001981. J Gen Virol. 2024. PMID: 38717926
-
Detection of Respiratory Viruses Other Than SARS-CoV-2 in a Large Hospital Laboratory in Rome, Italy, During the Seasons 2016-2017 to 2022-2023.Influenza Other Respir Viruses. 2025 Feb;19(2):e70079. doi: 10.1111/irv.70079. Influenza Other Respir Viruses. 2025. PMID: 39978409 Free PMC article.
-
Seasonality and Co-Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness-Valencia Region, Spain, 2010-2021.Influenza Other Respir Viruses. 2024 Oct;18(10):e70017. doi: 10.1111/irv.70017. Influenza Other Respir Viruses. 2024. PMID: 39439102 Free PMC article.
-
Altered epidemiological patterns of Respiratory Syncytial Virus and influenza detections in a tropical Australian setting 2020 to 2023.Aust N Z J Public Health. 2024 Aug;48(4):100172. doi: 10.1016/j.anzjph.2024.100172. Epub 2024 Jul 25. Aust N Z J Public Health. 2024. PMID: 39059095 Review.
Cited by
-
Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants.Influenza Other Respir Viruses. 2025 May;19(5):e70105. doi: 10.1111/irv.70105. Influenza Other Respir Viruses. 2025. PMID: 40302169 Free PMC article.
References
-
- Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al.. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 2020;396:1204–22. doi: 10.1016/S0140-6736(20)30925-9 - DOI - PMC - PubMed
-
- Australian Institute of Health and Welfare. Infectious and communicable diseases. Canberra: 2022.
-
- ANZICS Centre for Outcome and Resource Evaluation. Australia and New Zealand Paediatric Intensive Care Registry Activity Report 2018. Melbourne: 2019.
-
- Centre for Epidemiology and Evidence, NSW Ministry of Health. HealthStats NSW Acute respiratory infection hospitalisations. NSW Combined Admitted Patient Epidemiology Data and ABS Population Estimates (SAPHaRI) 2020. http://www.healthstats.nsw.gov.au/Indicator/res_acreshos/res_acreshos?&t... (accessed November 23, 2021).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous